Inflammation study in vitiligo and other skin conditions
Treatments studied
Part of Genetic & congenital, Immune system & allergy, Skin clinical trials.
This study looks at inflammation in people with vitiligo, psoriasis, atopic dermatitis, or alopecia areata. It aims to understand how these conditions compare, which may lead to better treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 75 years old.
- You must have non-segmental vitiligo, plaque psoriasis, atopic dermatitis, or alopecia areata.
- If you are using a topical cream for your condition, you must have been on it for at least 2 weeks.
- If you are on systemic (pill or shot) treatments, you must have been on them for at least 4 weeks.
- You cannot be pregnant or breastfeeding.
- You must have health insurance (social security) and be able to give informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at what affects the “path” (trajectory) of long-lasting inflammatory skin conditions. It may help researchers understand why symptoms change and how treatments or factors influence those changes.
This study is looking at whether levels of certain immune proteins (called cytokines) in your blood can help predict how vitiligo will progress. By participating, you help doctors develop a tool to better plan treatment and understand your condition.
This study looks at how people view those with certain skin conditions. It aims to understand stigma, which may help improve awareness and support.
This study looks for clues in your skin and blood that could predict how well you'll respond to treatments for conditions like eczema, psoriasis, or lupus. It aims to help doctors choose the best therapy for you.
This study looks at the health records of people with certain inflammatory skin diseases (such as psoriasis or eczema) in Italy to understand who gets them and what treatments they receive. By joining, you help doctors learn more about how these conditions are managed in real life.
This study looks at differences in the gut and skin microbiome (the germs living in and on the body) in people with vitiligo and in people without vitiligo. It aims to understand what might be linked to how vitiligo spreads over time.
Hear when a new Vitiligo trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.